Open Access Open Access  Restricted Access Subscription Access

Influence of Estrogen on Migraine

Madhuri S. Patil, Divakar R. Patil, Akash S. Jain, Azam Z. Shaikh, Sameer R. Shaikh, Dr. S. P. Pawar

Abstract


Migraine attacks for longer periods of time. Ten to twelve percent of people have this persistent neurological condition. On contrasting men and women Compared to males, women experience headaches more frequently, more intensely, and for longer periods of time. The hypothalamic hypophyseal-ovarian axis controls the release of progesterone and estrogen in women's reproductive cycles. Pregnancy, puerperium, menopause, and the menstrual cycle are all governed and controlled by changes in these hormone levels. There are two stages to this: the luteal or ovulatory phase and the follicular or proliferative phase. Aura-free migraine and aura-accompanied migraine are the two main forms of migraine. About 12–15% of people worldwide suffer from migraines, a widespread and incapacitating neurological condition that is two to three times more common in women than in men. In addition to being more likely to suffer from psychiatric comorbidities such anxiety and depression, women also have migraines more frequently, with higher intensity and longer duration. The pathophysiology of migraines is significantly influenced by estrogen, and the loss of estrogen prior to menstruation is a prominent cause. In migraine-related brain areas, estrogen affects gene expression, neuronal excitability, and pain regulation through the receptors ERα, ERβ, and GPER. Migraines are more common, more severe, and associated with comorbid conditions including anxiety and depression in women and menopause. The pathophysiology of migraines is significantly impacted by these hormonal shifts. Up to 20% of people suffer from migraines, which are more common in women. They are characterized by unilateral, pulsing pain that is frequently accompanied by phonophobia, photophobia, and nausea. Vasoactive peptides such nitric oxide, PACAP, and CGRP are among the neurological and vascular pathways involved in the pathophysiology. The decrease in estrogen during the late luteal phase is closely associated with menstrual migraines, which can result in more frequent and severe attacks.


Full Text:

PDF

References


Devika J. J., Lijolin V. S., Prasobh G. R.and Grace N. Raju (2021). Role Of Hormones And Migraine Headache During Womens LIFE. World Journal of Pharmaceutical Research,10, (9),171-178.

Poojitha Mamindla., et al. “A Review on Migraine”. Acta Scientific Pharmaceutical Sciences 3.1 (2019): 29-42.

Li, S., & Zhang, J. (2025c). Association between magnesium intake and migraine among pre and Postmenopausal Women: A Cross-Sectional study. International Journal of Women S Health, Volume 17, 2747–275.

Nappi, R. E., Tiranini, L., Sacco, S., De Matteis, E., De Icco, R., & Tassorelli, C. (2022). Role of Estrogens in Menstrual Migraine. Cells, 11(8), 1355.

Sacco, S., Ricci, S., Degan, D., & Carolei, A. (2012). Migraine in women: the role of hormones and their impact on vascular diseases. The Journal of Headache and Pain, 13(3), 177–189.

Gomez, L. D. (2022). Exogenous and endogenous female sex hormones: Impact on women with migraine (Thesis). Lithuanian University of Health Sciences, Faculty of Medicine.

Raffaelli, B., Phu, T., DO, Chaudhry, B. A., Ashina, M., Amin, F. M., & Ashina, H. (2023). Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence. The Journal of Headache and Pain, 24(1).

Turankar, T., Sorte, A., Wanjari, M. B., Chakole, S., & Sawale, S. (2023). Relation and Treatment approach of migraine in pregnancy and breastfeeding.

Godley, F., Meitzen, J., Nahman-Averbuch, H., O’Neal, M. A., Yeomans, D., Santoro, N., Riggins, N., & Edvinsson, L. (2024b). How sex Hormones Affect Migraine: An Interdisciplinary Preclinical Research Panel review. Journal of Personalized Medicine, 14(2), 184.

Barbanti, P., & Nappi, R. E. (2025). Framing and Management of Migraines in Women: An expert opinion on challenges, current approaches, and future multidisciplinary perspectives. Healthcare, 13(2), 164.


Refbacks

  • There are currently no refbacks.